As of 2026-09-22, the Relative Valuation of Biosynex SA (ALBIO.PA) is (38.33) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 EUR, the upside of Biosynex SA based on Relative Valuation is -4359.3%.
The range of the Relative Valuation is (33.62) - (41.57) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 11.0x | 9.2x |
| Forward P/E multiples | 8.9x - 13.3x | 11.1x |
| Fair Price | (33.62) - (41.57) | (38.33) |
| Upside | -3835.5% - -4719.0% | -4359.3% |
| Date | P/E |
| 2026-09-16 | -0.24 |
| 2026-09-15 | -0.24 |
| 2026-09-14 | -0.24 |
| 2026-09-11 | -0.24 |
| 2026-09-10 | -0.25 |
| 2026-09-09 | -0.25 |
| 2026-09-08 | -0.24 |
| 2026-09-07 | -0.25 |
| 2026-09-04 | -0.24 |
| 2026-09-03 | -0.23 |
| 2026-09-02 | -0.23 |
| 2026-09-01 | -0.24 |
| 2026-08-31 | -0.24 |
| 2026-08-28 | -0.24 |
| 2026-08-27 | -0.24 |
| 2026-08-26 | -0.24 |
| 2026-08-25 | -0.24 |
| 2026-08-24 | -0.24 |
| 2026-08-21 | -0.24 |
| 2026-08-20 | -0.25 |
| 2026-08-19 | -0.24 |
| 2026-08-18 | -0.25 |
| 2026-08-17 | -0.25 |
| 2026-08-14 | -0.25 |
| 2026-08-13 | -0.26 |
| 2026-08-12 | -0.26 |
| 2026-08-11 | -0.24 |
| 2026-08-10 | -0.24 |
| 2026-08-07 | -0.24 |
| 2026-08-06 | -0.24 |
| 2026-08-05 | -0.24 |
| 2026-08-04 | -0.24 |
| 2026-08-03 | -0.24 |
| 2026-07-31 | -0.24 |
| 2026-07-30 | -0.24 |
| 2026-07-29 | -0.24 |
| 2026-07-28 | -0.24 |
| 2026-07-27 | -0.25 |
| 2026-07-24 | -0.24 |
| 2026-07-23 | -0.25 |
| 2026-07-22 | -0.25 |
| 2026-07-21 | -0.25 |
| 2026-07-20 | -0.24 |
| 2026-07-17 | -0.24 |
| 2026-07-16 | -0.24 |
| 2026-07-15 | -0.24 |
| 2026-07-14 | -0.24 |
| 2026-07-13 | -0.24 |
| 2026-07-10 | -0.23 |
| 2026-07-09 | -0.24 |